Understanding the regulatory foundation behind translated informed consent documents and why many institutional review boards (IRBs) require certificates or attestations of translation.
ACRO Global Summit brings together senior regulators and industry leaders from around the world to discuss the evolving regulatory landscape
Gene therapies and gene-based therapeutics are giving way to a new era of interventional genetics. Integrated ethics review and biosafety review have developed into an operational advantage to facilitate this
Cardiovascular disease remains a worldwide challenge, causing undue strain on the health system and contributing substantial patient burden. For decades, our medical response has been
ACRO Global Summit brings together senior regulators and industry leaders from around the world to discuss the evolving regulatory landscape
A note from Lauri Carlile, Chief Research Services Officer: For more than 40 years, Advarra’s institutional review board (IRB) has
Kyle Naylor didn’t set out to work in the IRB world—but once he found it, he never looked back. Now a team lead supporting
Rethinking oversight as clinical trials become more data-driven and algorithm-informed As artificial intelligence (AI) becomes more embedded in clinical trial
Heading to the Advarra Innovation Summit in London? Share the news and encourage your peers and partners to join you!
MaryJo Carter has spent more than nine years at Advarra, growing alongside the organization and helping shape how teams show up for
Balancing innovation, statistical rigor, and independent oversight in increasingly complex clinical trials Clinical trials are no longer static. Over the
Evan Sander knows firsthand that clinical research is never just about processes or paperwork—it’s about people. As associate director of
